Suppr超能文献

用于桥接肺移植的体外膜肺氧合(ECMO)。

ECMO for bridging lung transplantation.

作者信息

Zhang Chuhan, Wang Qingjing, Lu Anwei

机构信息

School of Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.

Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310022, People's Republic of China.

出版信息

Eur J Med Res. 2024 Dec 26;29(1):628. doi: 10.1186/s40001-024-02239-y.

Abstract

BACKGROUND

With the shift in donor lung allocation from blood type and waiting order to the use of the lung allocation score (LAS) system, there are increasingly more cases of ECMO bridging lung transplantation. However, there are still some problems in case selection, implementation, and management.

METHODS

We analyzed and summarized a series of data on ECMO bridging lung transplantation through an extensive literature review.

RESULTS

The improvement of the lung transplant allocation system and the progress of ECMO technology have made the ECMO bridge to lung transplant more widely used in clinical practice. The selection of bridge patients is a crucial link in the success of transplantation, and accurate assessment of the patient before transplantation is necessary. The advantages and disadvantages of different bridge strategies exist, and the appropriate bridge strategy should be selected based on the patient's situation. Bleeding and thrombosis complications often occur during ECMO circulation, and there is currently no optimal anticoagulation strategy. The predictive score for bridge post-outcome is still subject to certain limitations.

CONCLUSIONS

ECMO bridging lung transplantation is suitable for patients waiting for lung transplantation when other respiratory support is ineffective or when hemodynamic instability occurs the disease is severe and the donor organ is easily obtainable. Patients aged 65 years or older, or have reversible multiple organ dysfunction should not be included as contraindications for ECMO bridging lung transplantation.

摘要

背景

随着供肺分配从血型和等待顺序转向使用肺分配评分(LAS)系统,体外膜肺氧合(ECMO)桥接肺移植的病例越来越多。然而,在病例选择、实施和管理方面仍存在一些问题。

方法

我们通过广泛的文献综述分析和总结了一系列关于ECMO桥接肺移植的数据。

结果

肺移植分配系统的改进和ECMO技术的进步使ECMO桥接肺移植在临床实践中得到更广泛的应用。桥接患者的选择是移植成功的关键环节,移植前对患者进行准确评估是必要的。不同桥接策略各有优缺点,应根据患者情况选择合适的桥接策略。ECMO循环期间常发生出血和血栓形成并发症,目前尚无最佳抗凝策略。桥接后结局的预测评分仍存在一定局限性。

结论

ECMO桥接肺移植适用于其他呼吸支持无效或出现血流动力学不稳定、病情严重且供体器官易于获取时等待肺移植的患者。65岁及以上或有可逆性多器官功能障碍的患者不应作为ECMO桥接肺移植的禁忌证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9a/11670462/9b6023c836df/40001_2024_2239_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验